CD19 and lymphoma: Interestingly, treatment with CD19-28BBζ prolonged the survival of lymphoma-bearing mice to a greater extent than treatment with CD19-BBζ CAR T cells, indicating that 4-1BB molecule enhances the co-stimulatory properties of the CD28 molecule in umbilical cord blood T cells.